Boehringer Ingelheim to Cap Out of Pocket Inhaler Costs at $35 Per Month - Drug Topics

Retrieved on: 2024-03-07 20:22:01

Tags for this article:

Click the tags to see associated articles and topics

Boehringer Ingelheim to Cap Out of Pocket Inhaler Costs at $35 Per Month - Drug Topics. View article details on hiswai:

Excerpt

Pfizer's RSV vaccine received FDA approval on May 31, 2023. Advertisement. Pfizer's respiratory syncytial virus (RSV) vaccine Abrysvo remains ...

Article found on: www.drugtopics.com